Mafalda Oliveira
Barcelona breast oncologist who leads SOLTI, the Spanish academic breast cancer research group, and co-authors pivotal endocrine therapy trials.
Overview
Mafalda Oliveira is President of SOLTI Cancer Research Group, the Spanish academic cooperative group focused on breast cancer clinical and translational research. A medical oncologist at Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology in Barcelona, she has been an investigator on major trials of novel endocrine and targeted agents in hormone receptor-positive breast cancer, including CAPItello-291 and SERENA-2. Her role is listed on SOLTI's board page.
Pages like this
not linked directly; found by shared links- PersonEva Ciruelos
Shares SOLTI Cancer Research Group, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonMichael Gnant
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
- PersonPriya Rastogi
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
- PersonNorman Wolmark
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer, clinical trials.
- PersonDorraya El-Ashry
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonJason Carroll
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonAnna Sapino
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
- PersonTari A. King
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.